Neovacs SA (FR:ALNEV) has released an update.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Neovacs SA, a French biotech firm, announced changes in its share capital and total number of voting rights, following a consolidation and the issuance of new shares. The company, known for its innovative kinoid® technology for treating autoimmune diseases, also informed about the potential market risks due to dilutive financing operations. Investors are cautioned about the possible impact on share value and capital dilution from these financial strategies.
For further insights into FR:ALNEV stock, check out TipRanks’ Stock Analysis page.